The role of correction of anaemia in patients with congestive heart failure: a short review (Q37243581)

19 August 2017

1 reference

title

The role of correction of anaemia in patients with congestive heart failure: a short review (English)

1 reference

19 August 2017

0 references

0 references

congestive heart failure

1 reference

Donald S Silverberg

1

1 reference

19 August 2017

Dov Wexler

series ordinal

2

1 reference

19 August 2017

Adrian Iaina

series ordinal

3

1 reference

19 August 2017

Doron Schwartz

series ordinal

4

1 reference

19 August 2017

15 August 2008

1 reference

European Journal of Heart Failure

19 August 2017

1 reference

19 August 2017

10

1 reference

19 August 2017

9

1 reference

19 August 2017

819-823

1 reference

The interaction between heart failure and other heart diseases, renal failure, and anemia

19 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.06.015

Prevalence of anemia and effects on mortality in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.06.015

The prevalence of anemia in chronic heart failure and its impact on the clinical outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.06.015

Anemia and change in hemoglobin over time related to mortality and morbidity in patients with chronic heart failure: results from Val-HeFT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.06.015

The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.06.015

The effect of correction of anaemia in diabetics and non-diabetics with severe resistant congestive heart failure and chronic renal failure by subcutaneous erythropoietin and intravenous iron

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.06.015

Correction of anemia in patients with congestive heart failure increases resting energy expenditure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.06.015

Effects of treatment with epoetin beta on outcomes in patients with anaemia and chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.06.015

Improvement of anemia with erythropoietin and intravenous iron reduces sleep-related breathing disorders and improves daytime sleepiness in anemic patients with congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.06.015

The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.06.015

Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.06.015

Effects of darbepoetin-alpha on plasma pro-inflammatory cytokines, anti-inflammatory cytokine interleukin-10 and soluble Fas/Fas ligand system in anemic patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.06.015

Effects of darbepoetin alpha on right and left ventricular systolic and diastolic function in anemic patients with chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.06.015

Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.06.015

Effects of beta-erythropoietin treatment on left ventricular remodeling, systolic function, and B-type natriuretic peptide levels in patients with the cardiorenal anemia syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.06.015

Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure and anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.06.015

Effect of darbepoetin alfa on exercise tolerance in anemic patients with symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.06.015

Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.06.015

Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.06.015

Normalization of hemoglobin level in patients with chronic kidney disease and anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.06.015

Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.06.015

The non-haematopoietic biological effects of erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.06.015

Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.06.015

Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.06.015

Etiology of anemia in patients with advanced heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.06.015

Heart failure and anemia: mechanisms and pathophysiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.06.015

Ferric gluconate reduces epoetin requirements in hemodialysis patients with elevated ferritin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.06.015

Intravenous ferric gluconate significantly improves response to epoetin alfa versus oral iron or no iron in anemic patients with cancer receiving chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.06.015

Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: a multicenter, open-label, randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.06.015

Are erythropoietin stimulating proteins safe and efficacious in heart failure? Why we need an adequately powered randomised outcome trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.06.015

Relation of low hemoglobin and anemia to morbidity and mortality in patients hospitalized with heart failure (insight from the OPTIMIZE-HF registry).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.06.015

Overview of emerging pharmacologic agents for acute heart failure syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.06.015

Randomized, double-blind, placebo-controlled study to evaluate the effect of two dosing regimens of darbepoetin alfa in patients with heart failure and anaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.06.015

Secular Trends in Renal Dysfunction and Outcomes in Hospitalized Heart Failure Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.06.015

An Ongoing Study of Anemia Correction in Chronic Kidney Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.06.015

Haemoglobin targets: we were wrong, time to move on

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.06.015

10.1016/J.EJHEART.2008.06.015

21 January 2018

Identifiers

DOI

1 reference

19 August 2017

1 reference